Reaction

Which drugs are most reported with Intercepted product administration error?

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 7,619 reports · 21 co-occurring drugs

As of the last recalculation, Intercepted Product Administration Error appears in 7,619 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is EPOETIN ALFA (PRR 67.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Epoetin Alfa28367.769.4
Evolocumab2,52062.963.9
Erenumab-Aooe1,02158.359.4
Romosozumab-Aqqg11523.523.7
Darbepoetin Alfa38620.620.7
Denosumab1,21219.319.4
Romiplostim9918.218.3
Blinatumomab5614.814.8
Leuprolide Acetate33512.312.3
Pegfilgrastim35610.310.3
Carfilzomib10210.010.0
Filgrastim946.96.9
Panitumumab396.86.8
Etanercept6863.33.3
Erythropoietin212.82.8
Umeclidinium72.12.1
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate201.31.3
Cabotegravir31.01.0
Somatropin140.50.5
Apremilast220.40.4
Nirmatrelvir And Ritonavir70.40.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.